FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/069949 [Registered on: 04/07/2024] Trial Registered Prospectively
Last Modified On: 02/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to evaluate the efficacy of dhatrirasadiprayog in the management of vomiting in school going children  
Scientific Title of Study   Open randomized controlled clinical study on the efficasy of dhatrirasadiprayog in the management of chhardi in children 
Trial Acronym  Nil  
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Parag Dattakumar Nanaware 
Designation  PG Scholar 
Affiliation  Hon Shri Annasaheb Dange Ayurved Medical College Post Gaduate And Research Center Ashta 
Address  Dhanvantari Ayurved Hospital Ashta Balrog OPD Room no 10 Ground Floor

Sangli
MAHARASHTRA
416301
India 
Phone  8856986819  
Fax    
Email  paragnanaware79@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nareshkumar Babar  
Designation  Reader 
Affiliation  Hon Shri Annasaheb Dange Ayurved Medical College Post Gaduate And Research Center Ashta 
Address  3rd Floor Department Of Balrog Hon Shri Annasaheb Dange Ayurved Medical College Post Gaduate And Research Center Ashta

Sangli
MAHARASHTRA
416301
India 
Phone  7507595454  
Fax    
Email  dr.nareshbabar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nareshkumar Babar  
Designation  Reader 
Affiliation  Hon Shri Annasaheb Dange Ayurved Medical College Post Gaduate And Research Center Ashta 
Address  3rd Floor Department Of Balrog Hon Shri Annasaheb Dange Ayurved Medical College Post Gaduate And Research Center Ashta

Sangli
MAHARASHTRA
416301
India 
Phone  7507595454  
Fax    
Email  dr.nareshbabar@gmail.com  
 
Source of Monetary or Material Support  
Hon Shri Annasaheb Dange Ayurved Medical College Post Gaduate And Research Center Ashta Tal Walwa Dist sangali Maharashtra 416301 india  
 
Primary Sponsor  
Name  Dr Parag Dattakumar Nanaware 
Address  OPD no 10 Balrog OPD Ground Floor Dhanvantari Ayurved Hospital Ashta Tal Walwa Dist Sangli Maharashtra 416301 india 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Parag Dattakumar Nanaware  Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta  Dhanvantari Ayurved Hospital Ashta Balrog OPD Room No 10 Ground Floor
Sangli
MAHARASHTRA 
8856986819

paragnanaware79@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Hon Annasaheb Dange Ayurved Medical College Post Graduate And Research Centre Ashta Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K00-K95||Diseases of the digestive system. Ayurveda Condition: CARDIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Haritaki Churna, Reference: Bhaishjyaratnavali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 1.8(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 5 Days, anupAna/sahapAna: Yes(details: Madhu), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Dhatrirasadiprayog, Reference: Chakradatta, Route: Oral, Dosage Form: Avleha/Leha/Paka/Raskriya, Dose: 14.4(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 5 Days, anupAna/sahapAna: Yes(details: Madhu), Additional Information: -
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  1 vomiting due to Indigestion over eating and excessive intake of liquid diet
2 Vomiting due to incompatible spicy diet
3 vomiting due to fried food dried food packed and tinned food  
 
ExclusionCriteria 
Details  1 Patients of Sannipataj and Bibhtsadarshanj Chhardi
2 Patients with moderate and severe Dehydration
3 Patient suffering from Atisara associated Chhardi
4 Patient suffering from jwar
5 patients with disorder like Liver cirrhosis Renal failure poisoning Hyperthyroidism Congenital anamolies Head injury metabolic disorder
6 Surgical condition like Cholecystitis Intestinal obstruction Cancer of Stomach  
 
Method of Generating Random Sequence   Other 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To Evaluate the Efficacy of Dhatrirasadiprayog in the management of Chhardi in Childrens  5 days  
 
Secondary Outcome  
Outcome  TimePoints 
To compare the Efficacy of Dhatrirasadiprayog and Haritaki churna in management of Chhardi in children  5 days 
 
Target Sample Size   Total Sample Size="78"
Sample Size from India="78" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   As we see the number of patients with Chhardi are increasing now a days due to fast food , spicy , extra oily food , eating packaged food , so this study help to relieve the symptoms . The study is open randomized controlled trial in which Dhatrirasadiprayog is trial drug and Haritaki Churna is controlled drug . Study will be carried out for 5 days including 1st , 3 rd , 5th day followup . 39 Patients will studied in each group . Study will be conducted in India . Outcome of study will be asses on reduction of sign and Symptoms of Chhardi in Childrens . 
Close